T. van der Vaart

A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex

D. Rizopoulos, H. Moll, F. Jansen, 2019, Neurology.

Update from the 2013 international neurofibromatosis conference

Michael Fisher, A. Lloyd, A. Stemmer-Rachamimov, 2014, American journal of medical genetics. Part A.

Recent developments in neurofibromatoses and RASopathies: Management, diagnosis and current and future therapeutic avenues

M. Patton, S. Huson, M. Vikkula, 2015, American journal of medical genetics. Part A.

Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1

H. Moll, E. Legius, E. Plasschaert, 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Treatment of Cognitive Deficits in Genetic Disorders: A Systematic Review of Clinical Trials of Diet and Drug Treatments.

H. Moll, Y. Elgersma, R. Oostenbrink, 2015, JAMA Neurology.

Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum

C. D. De Zeeuw, M. Schonewille, Y. Elgersma, 2011, Genes, brain, and behavior.

Within-subject consistency of paired associative stimulation as assessed by linear mixed models

Y. Elgersma, J. Tulen, L. Fani, 2018, bioRxiv.

Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1

H. Moll, E. Legius, Y. Elgersma, 2016, Neurology.

OS07.8.A Prognosis in IDH-mutant glioma: the role of extent-of-resection, age and tumor grade

M. J. van den Bent, P. French, J. Kros, 2022, Neuro-Oncology.